机构:[1]Department of Nephrology, the First Affiliated Hospital of Shenzhen University, the Second People’s Hospital of Shenzhen, Shenzhen 518035, China深圳市第二人民医院深圳市康宁医院深圳医学信息中心[2]Shenzhen University Health Science Center, Department of Pathology, Shenzhen University, Shenzhen 518071, China深圳市康宁医院深圳医学信息中心[3]Department of Medicine & Therapeutics, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China[4]Advanced Institute for Medical Sciences, Dalian Medical University, Dalian 116044, Liaoning, China[5]The First Affiliated Hospital of Shenzhen University, Health Science Center, China深圳市第二人民医院深圳医学信息中心[6]Guangdong-Hong Kong Joint Laboratory on Immunological and Genetic Kidney Diseases, Guangdong Academy of Medical Sciences, Guangdong Provincial People’s Hospital, Guangzhou 510080, China[7]Department of Physiology at the Basic Medical College, Shenzhen University Health Science Center, Shenzhen 518071, China深圳市康宁医院深圳医学信息中心[8]Health Science Center, East China Normal University, Shanghai 200241, China[9]Center for Innovative Medicine, Department of Biosciences and Nutrition, Karolinska Institute, Stockholm, Sweden[10]Center for Nuclear Receptors and Cell Signaling, University of Houston, Houston, USA[11]Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Sciences & Medical Engineering, Southeast University, Nanjing 210000, China[12]Research Center for Integrative Medicine, the Affiliated Traditional Medicine Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China[13]The Second People’s Hospital of Shenzhen, Institute of Translational Medicine, Medical Research Center, China
This work was supported by Guangdong Basic and Applied Basic Research Foundation (2021A1515010991); The Shenzhen Science and Technology Project (JCYJ20210324103602006 & JCYJ202103240 94213037); The Shenzhen Second People’s Hospital Clinical Research Project (20223357004); The National Natural Science Foundation of China (No. 81600534, 81870405, 81970606, 81970595 & 82270703); The Shenzhen Key Medical Discipline Construction Fund (SZXK009); Research Grants Council of Hong Kong (14117418, 14104019, 14101121); The Guangdong-Hong Kong-Macao-Joint Labs Program from Guangdong Science and Technology Department (2019B121205005); The Lui Che Woo Institute of Innovative Medicine (CARE program); And the National Key Research and Development Program of China (2020YFC2005000).
第一作者机构:[1]Department of Nephrology, the First Affiliated Hospital of Shenzhen University, the Second People’s Hospital of Shenzhen, Shenzhen 518035, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Cao Rong,Su Wen,Sheng Jingyi,et al.Estrogen receptor β attenuates renal fibrosis by suppressing the transcriptional activity of Smad3[J].BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE.2023,1869(6):doi:10.1016/j.bbadis.2023.166755.
APA:
Cao Rong,Su Wen,Sheng Jingyi,Guo Yanlin,Su Jie...&Guan Youfei.(2023).Estrogen receptor β attenuates renal fibrosis by suppressing the transcriptional activity of Smad3.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE,1869,(6)
MLA:
Cao Rong,et al."Estrogen receptor β attenuates renal fibrosis by suppressing the transcriptional activity of Smad3".BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1869..6(2023)